Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin Kline

Showing results (41-50 of 99) with videos related to

Pageof 10
Sort By:
Haematologica|December 16, 2021
Loss of 5-hydroxymethylcytosine expression is near-universal in B-cell lymphomas with variable mutations in epigenetic regulatorsKevin S Tanager, Jovian Yu, Brian C-H Chiu, et al.
Nature Medicine|September 1, 2015
CD47 blockade triggers T cell-mediated destruction of immunogenic tumorsXiaojuan Liu, Yang Pu, Kyle Cron, et al.
Leukemia|November 30, 2021
Acute myeloid leukemia cell membrane-coated nanoparticles for cancer vaccination immunotherapyDaniel T Johnson, Jiarong Zhou, Ashley V Kroll, et al.
Immunity|May 26, 2022
Dendritic cells can prime anti-tumor CD8<sup>+</sup> T cell responses through major histocompatibility complex cross-dressingBrendan W MacNabb, Sravya Tumuluru, Xiufen Chen, et al.
Blood|March 27, 2019
<i>PD-L1</i> gene alterations identify a subset of diffuse large B-cell lymphoma harboring a T-cell-inflamed phenotypeJames Godfrey, Sravya Tumuluru, Riyue Bao, et al.
Immunity|November 9, 2022
Dendritic cells can prime anti-tumor CD8<sup>+</sup> T cell responses through major histocompatibility complex cross-dressingBrendan W MacNabb, Xiufen Chen, Sravya Tumuluru, et al.
Cytotherapy|May 3, 2012
Influence of related donor age on outcomes after peripheral blood stem cell transplantationElie M Richa, Rangesh Kunnavakkam, Lucy A Godley, et al.
British Journal of Haematology|August 10, 2013
A phase I/II trial of bortezomib combined concurrently with gemcitabine for relapsed or refractory DLBCL and peripheral T-cell lymphomasAndrew M Evens, Steven T Rosen, Irene Helenowski, et al.
Leukemia & Lymphoma|December 25, 2015
Incidence and predictors of respiratory viral infections by multiplex PCR in allogeneic hematopoietic cell transplant recipients 50 years and older including geriatric assessmentChristopher R D'Angelo, Masha Kocherginsky, Jennifer Pisano, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 15, 2011
Phase I-II study of clofarabine-melphalan-alemtuzumab conditioning for allogeneic hematopoietic cell transplantationKoen van Besien, Wendy Stock, Elizabeth Rich, et al.
Pageof 10

Showing results (41-50 of 99) with videos related to

Sort By:
Pageof 10
Haematologica|December 16, 2021
Loss of 5-hydroxymethylcytosine expression is near-universal in B-cell lymphomas with variable mutations in epigenetic regulatorsKevin S Tanager, Jovian Yu, Brian C-H Chiu, et al.
Nature Medicine|September 1, 2015
CD47 blockade triggers T cell-mediated destruction of immunogenic tumorsXiaojuan Liu, Yang Pu, Kyle Cron, et al.
Leukemia|November 30, 2021
Acute myeloid leukemia cell membrane-coated nanoparticles for cancer vaccination immunotherapyDaniel T Johnson, Jiarong Zhou, Ashley V Kroll, et al.
Immunity|May 26, 2022
Dendritic cells can prime anti-tumor CD8<sup>+</sup> T cell responses through major histocompatibility complex cross-dressingBrendan W MacNabb, Sravya Tumuluru, Xiufen Chen, et al.
Blood|March 27, 2019
<i>PD-L1</i> gene alterations identify a subset of diffuse large B-cell lymphoma harboring a T-cell-inflamed phenotypeJames Godfrey, Sravya Tumuluru, Riyue Bao, et al.
Immunity|November 9, 2022
Dendritic cells can prime anti-tumor CD8<sup>+</sup> T cell responses through major histocompatibility complex cross-dressingBrendan W MacNabb, Xiufen Chen, Sravya Tumuluru, et al.
Cytotherapy|May 3, 2012
Influence of related donor age on outcomes after peripheral blood stem cell transplantationElie M Richa, Rangesh Kunnavakkam, Lucy A Godley, et al.
British Journal of Haematology|August 10, 2013
A phase I/II trial of bortezomib combined concurrently with gemcitabine for relapsed or refractory DLBCL and peripheral T-cell lymphomasAndrew M Evens, Steven T Rosen, Irene Helenowski, et al.
Leukemia & Lymphoma|December 25, 2015
Incidence and predictors of respiratory viral infections by multiplex PCR in allogeneic hematopoietic cell transplant recipients 50 years and older including geriatric assessmentChristopher R D'Angelo, Masha Kocherginsky, Jennifer Pisano, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 15, 2011
Phase I-II study of clofarabine-melphalan-alemtuzumab conditioning for allogeneic hematopoietic cell transplantationKoen van Besien, Wendy Stock, Elizabeth Rich, et al.
Pageof 10